AI has created new cybersecurity threats as well as solutions. Sentinel is now able to respond to threats more autonomously. Microsoft is capitalizing on the industry's period of transition. The rise ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...

The Graph is in a continuous downtrend with prices not respecting any support levels. Investors are keen to know if this token which claims to have strong fundamentals, has the capacity to recover in ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top of ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Discover how to effortlessly create stunning, interactive charts with Syncfusion in .NET MAUI. Enhance your mobile and desktop applications with powerful data visualization features using this ...

npm i https://github.com/jodymgustafson/math-graph-canvas/releases/download/v1.1.0/math-graph-canvas-1.1.0.tgz Use the CartesianGraph class to create a cartesian ...

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (“Cartesian” or the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for ...

Astellas is putting the kibosh on a potential $340 million licensing deal it inked last year with Cartesian Therapeutics to develop a treatment for Pompe disease, according to an SEC filing on ...